Renal Cancer
Tumor response criteria for assessing pazopanib first-line therapy in patients with metastatic renal cell carcinoma (mRCC).
January 3, 2020
Prognostic value of infiltrating immune cells in clear cell renal cell carcinoma (ccRCC).
January 3, 2020
Three novel hub genes and their clinical significance in clear cell renal cell carcinoma.
January 2, 2020
The covalent CDK7 inhibitor THZ1 enhances temsirolimus-induced cytotoxicity via autophagy suppression in human renal cell carcinoma.
January 2, 2020
Predictors of Cytoreductive Nephrectomy for Metastatic Kidney Cancer in SEER and Metropolitan Detroit Databases.
January 2, 2020
Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals.
January 1, 2020
Cancer-Specific Loss of Urocortin 3 in Human Renal Cancer.
January 1, 2020
The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
December 31, 2019
Screening, identification and validation of CCND1 and PECAM1/CD31 for predicting prognosis in renal cell carcinoma patients.
December 30, 2019
MicroRNA-429 inhibits cancer cell proliferation and migration by targeting AKT1 in renal cell carcinoma.
December 30, 2019
The iron load of lipocalin-2 (LCN-2) defines its pro-tumour function in clear-cell renal cell carcinoma.
December 30, 2019
GPX1, a biomarker for the diagnosis and prognosis of kidney cancer, promotes the progression of kidney cancer.
December 27, 2019
A cluster of long non-coding RNAs exhibit diagnostic and prognostic values in renal cell carcinoma.
December 27, 2019